Search Results - Douglas G Altman

Doug Altman

Professor Douglas Altman Douglas Graham Altman FMedSci (12 July 1948 – 3 June 2018) was an English statistician best known for his work on improving the reliability and reporting of medical research and for highly cited papers on statistical methodology. He was professor of statistics in medicine at the University of Oxford, founder and Director of Centre for Statistics in Medicine and Cancer Research UK Medical Statistics Group, and co-founder of the international Equator Network for health research reliability. Provided by Wikipedia
  • Showing 1 - 13 results of 13
Refine Results
  1. 1
    Multi-reader multi-case studies using the area under the receiver operator characteristic curve as a measure of diagnostic accuracy: systematic review with a focus on quality of data reporting.

    Multi-reader multi-case studies using the area under the receiver operator characteristic curve as a measure of diagnostic accuracy: systematic review with a focus on quality of da... by Thaworn Dendumrongsup, Andrew A Plumb, Steve Halligan, Thomas R Fanshawe, Douglas G Altman, Susan Mallett

    Published 2014-01-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    THE REVISED CONSORT STATEMENT FOR REPORTING RANDOMIZED TRIALS: EXPLANATION AND ELABORATION (2001) (ENDING)

    THE REVISED CONSORT STATEMENT FOR REPORTING RANDOMIZED TRIALS: EXPLANATION AND ELABORATION (2001) (ENDING) by Douglas G. Altman, Kenneth F. Schulz, David Moher, Matthias Egger, Frank Davidoff, Diana Elbourne, Peter C. Gtzsche, Thomas Lang

    Published 2016-01-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    THE REVISED CONSORT STATEMENT FOR REPORTING RANDOMIZED TRIALS: EXPLANATION AND ELABORATION (2001) (PART II)

    THE REVISED CONSORT STATEMENT FOR REPORTING RANDOMIZED TRIALS: EXPLANATION AND ELABORATION (2001) (PART II) by Douglas G. Altman, Kenneth F. Schulz, David Moher, Matthias Egger, Frank Davidoff, Diana Elbourne, Peter C. Getzsche, Thomas Lang, N. Chipigina

    Published 2016-01-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    THE REVISED CONSORT STATEMENT FOR REPORTING RANDOMIZED TRIALS: EXPLANATION AND ELABORATION (2001)

    THE REVISED CONSORT STATEMENT FOR REPORTING RANDOMIZED TRIALS: EXPLANATION AND ELABORATION (2001) by Douglas G. Altman, Kenneth F. Schulz, David Moher, Matthias Egger, Frank Davidoff, Diana Elbourne, Peter C. G tzsche, Thomas Lang, N. Chipigina

    Published 2016-01-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    THE REVISED CONSORT STATEMENT FOR REPORTING RANDOMIZED TRIALS: EXPLANATION AND ELABORATION (2001) (CONTINUATION)

    THE REVISED CONSORT STATEMENT FOR REPORTING RANDOMIZED TRIALS: EXPLANATION AND ELABORATION (2001) (CONTINUATION) by Douglas G. Altman, Kenneth F. Schulz, David Moher, Matthias Egger, Frank Davidoff, Diana Elbourne, Peter C. G tzsche, Thomas Lang, N. Chipigina

    Published 2016-01-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Evidence for the selective reporting of analyses and discrepancies in clinical trials: a systematic review of cohort studies of clinical trials.

    Evidence for the selective reporting of analyses and discrepancies in clinical trials: a systematic review of cohort studies of clinical trials. by Kerry Dwan, Douglas G Altman, Mike Clarke, Carrol Gamble, Julian P T Higgins, Jonathan A C Sterne, Paula R Williamson, Jamie J Kirkham

    Published 2014-06-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Reporting and methods in clinical prediction research: a systematic review.

    Reporting and methods in clinical prediction research: a systematic review. by Walter Bouwmeester, Nicolaas P A Zuithoff, Susan Mallett, Mirjam I Geerlings, Yvonne Vergouwe, Ewout W Steyerberg, Douglas G Altman, Karel G M Moons

    Published 2012-01-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Choosing important health outcomes for comparative effectiveness research: An updated systematic review and involvement of low and middle income countries.

    Choosing important health outcomes for comparative effectiveness research: An updated systematic review and involvement of low and middle income countries. by Katherine Davis, Sarah L Gorst, Nicola Harman, Valerie Smith, Elizabeth Gargon, Douglas G Altman, Jane M Blazeby, Mike Clarke, Sean Tunis, Paula R Williamson

    Published 2018-01-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration

    Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration by Jan P. Vandenbroucke, Erik von Elm, Douglas G. Altman, Peter C. Gotzsche, Cynthia D. Mulrow, Stuart J. Pocock, Charles Poole, James J. Schlesselman, Matthias Egger

    Published 2022-07-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): Explanation and Elaboration. Translation into Russian

    Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): Explanation and Elaboration. Translation into Russian by Karel G.M. Moons, Douglas G. Altman, Johannes B. Reitsma, John P.A. Loannidis, Petra Macaskill, Ewout W. Steyerberg, Andrew J. Vickers, David F. Ransohoff, Gary S. Collins

    Published 2023-05-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration

    STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration by Jérémie F. Cohen, Daniël A. Korevaar, Douglas G. Altman, David E. Bruns, Constantine A. Gatsonis, Lotty Hooft, Les Irwig, Deborah Levine, Johannes B. Reitsma, Henrica C.W. de Vet, Patrick M.M. Bossuyt

    Published 2022-07-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic review.

    Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic review. by Jenni Hislop, Temitope E Adewuyi, Luke D Vale, Kirsten Harrild, Cynthia Fraser, Tara Gurung, Douglas G Altman, Andrew H Briggs, Peter Fayers, Craig R Ramsay, John D Norrie, Ian M Harvey, Brian Buckley, Jonathan A Cook, DELTA group

    Published 2014-05-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    CARE Guidelines for Case Reports: Explanation and Elaboration Document. Translation into Russian

    CARE Guidelines for Case Reports: Explanation and Elaboration Document. Translation into Russian by David S. Riley, Melissa S. Barber, Gunver S. Kienle, Jeffrey K. Aronson, Tido von Schoen-Angerer, Peter Tugwell, Helmut Kiene, Mark Helfand, Douglas G. Altman, Harold Sox, Paul G. Werthmann, David Moher, Richard A. Rison, Larissa Shamseer, Christian A. Koch, Gordon H. Sun, Patrick Hanaway, Nancy L. Sudak, Marietta Kaszkin-Bettag, James E. Carpenter, Joel J. Gagnier

    Published 2023-05-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: